ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,569.75
0.28%
US Tech 100
18,790.80
0.25%
Dow Jones
40,910.69
0.12%
Brent Oil
72.10
2.24%
Bitcoin
57,926.14
1.01%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Cardio Diagnostics Holdings Inc (CDIO) Quote

Cardio Diagnostics Holdings Inc

Cardio Diagnostics Holdings Inc (CDIO)

NASDAQ
0.2964
0.0057
( 1.96% )
Updated: 12:26:26
Delayed by 15 minutes

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Key stats and details

Current Price
0.2964
Bid
0.2964
Ask
0.2976
Volume
86,470
0.286 Day's Range 0.3097
0.171 52 Week Range 8.4999
Market Cap
7.097M
Previous Close
0.2907
Open
0.295
Last Trade
3
@
0.2964
Last Trade Time
12:26:03
Financial Volume
$ 25,890
VWAP
0.299405
Average Volume (3m)
371,533
Shares Outstanding
23,942,447
Dividend Yield
-
PE Ratio
-0.86
Earnings Per Share (EPS)
-0.35
Revenue
17k
Net Profit
-8.38M

About Cardio Diagnostics Holdings Inc

Cardio Diagnostics Holdings Inc is a biotechnology company that makes cardiovascular disease prevention and early detection more accessible, personalized, and precise. The company was formed to further develop and commercialize a proprietary artificial intelligence-driven integrated Genetic-Epigenet... Cardio Diagnostics Holdings Inc is a biotechnology company that makes cardiovascular disease prevention and early detection more accessible, personalized, and precise. The company was formed to further develop and commercialize a proprietary artificial intelligence-driven integrated Genetic-Epigenetic EngineTM for cardiovascular disease to become the leading medical technology company for enabling improved prevention, early detection, and assists in the treatment of cardiovascular disease. Show more

Sector
In Vitro,in Vivo Diagnostics
Industry
In Vitro,in Vivo Diagnostics
Headquarters
Dover, Delaware, USA
Founded
-
Cardio Diagnostics Holdings Inc is listed in the In Vitro,in Vivo Diagnostics sector of the NASDAQ with ticker CDIO. The last closing price for Cardio Diagnostics was $0.29. Over the last year, Cardio Diagnostics shares have traded in a share price range of $ 0.171 to $ 8.4999.

Cardio Diagnostics currently has 23,942,447 shares outstanding. The market capitalization of Cardio Diagnostics is $6.96 million. Cardio Diagnostics has a price to earnings ratio (PE ratio) of -0.86.

Ask ADVFN Intelligence (AI)

CDIO Latest News

More News

Cardio Diagnostics Holdings Inc. Launches CDIO.AI, A Redesigned Website Enhancing User Experience and Highlighting Our AI-Driven Cardiovascular Solutions

Cardio Diagnostics Holdings, Inc. (NASDAQ: CDIO), a leader in AI-powered precision cardiovascular medicine, today announced the launch of its redesigned website at CDIO.AI. This new site...

July 29 2024
Business Wire

Cardio Diagnostics Announces Its Epi+Gen CHD Heart Attack Risk Assessment Test is Now Available at Meijer Supercenter in McHenry, Illinois

Cardio Diagnostics Holdings, Inc. (NASDAQ: CDIO), an AI-driven precision cardiovascular medicine company, announced today that the Company’s clinical blood test, Epi+Gen CHD is now available at...

June 27 2024
Business Wire

Cardio Diagnostics Announces Its Epi+Gen CHD Heart Attack Risk Assessment Test is Now Available at Meijer Supercenter in McHenry, Illinois

Cardio Diagnostics Holdings, Inc. (NASDAQ: CDIO), an AI-driven precision cardiovascular medicine company, announced today that the Company’s clinical blood test, Epi+Gen CHD is now available at...

June 27 2024
Business Wire

Cardio Diagnostics Announces It’s Exhibiting at the 2024 Onsite Employee Health Clinics Forum

Cardio Diagnostics Holdings, Inc. (NASDAQ: CDIO), an AI-driven precision cardiovascular medicine company, announced today that the Company will sponsor a booth and showcase its groundbreaking...

June 25 2024
Business Wire

Cardio Diagnostics Holdings, Inc. Achieves SOC 2 Type I Compliance Certification for Security and Confidentiality

Cardio Diagnostics Holdings, Inc. (NASDAQ: CDIO), a leader in AI-driven precision cardiovascular medicine, today announced the successful completion of its System and Organization Controls (SOC...

June 10 2024
Business Wire

Cardio Diagnostics to Participate in the Centers for Medicare and Medicaid Services’ (CMS) Clinical Laboratory Fee Schedule (CLFS) Annual Meeting to Secure Medicare Payment for Its Innovative Tests

Company to recommend pricing for its Epi+Gen CHD and PrecisionCHD tests, and pursue coverage via the Molecular Diagnostic Services (MolDx) program. Cardio Diagnostics Holdings, Inc. (NASDAQ:...

May 21 2024
Business Wire

Cardio Diagnostics Holdings, Inc. Announces the Availability of Its Clinical Tests at Family Medicine Specialists’ Retail Healthcare Clinic at Walmart Supercenter in Round Lake Beach, Illinois, That Offers Walk-In Appointments Seven Days a Week

Cardio Diagnostics Holdings, Inc. (NASDAQ: CDIO), an AI-driven precision cardiovascular medicine company, announced today that the Company’s clinical blood tests, Epi+Gen CHD and PrecisionCHD...

May 13 2024
Business Wire

Cardio Diagnostics Announces Publication of Study Showing That its PrecisionCHD™ Test Could Save Health Insurers Over $113 Million Annually

The Peer-Reviewed Publication Demonstrates the Potential Economic Benefits of the PrecisionCHD™ Test for the Detection and Management of Coronary Heart Disease, which is One of the Largest Cost...

April 29 2024
Business Wire

Exponential Health Partners with Cardio Diagnostics to Elevate Cardiovascular Disease Prevention in Michigan

Exponential Health, an innovative concierge medicine practice in Michigan, adopts Cardio Diagnostics' AI-driven epigenetic-genetic tests, marking a new era in personalized and preventive cardiac...

April 09 2024
Business Wire

Cardio Diagnostics Holdings, Inc. Enters Into a Nationwide Telehealth Agreement with Navierre

Cardio Diagnostics Holdings, Inc. (NASDAQ: CDIO), an AI-driven precision cardiovascular medicine company, announces a strategic partnership with Navierre, an innovative digital health technology...

April 04 2024
Business Wire
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.1276-30.09433962260.4240.460.26052237190.33699096CS
4-0.2236-430.520.650.26052460100.44570793CS
12-1.0736-78.36496350361.371.580.26053715330.77716431CS
26-0.1336-31.06976744190.433.560.17139720681.3047275CS
52-3.9536-93.02588235294.258.49990.17127153022.01079054CS
156-3.9536-93.02588235294.258.49990.17127153022.01079054CS
2600000.364000CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
GVVisionary Holdings Inc
$ 5.00
(146.31%)
38.69M
EGIOEdgio Inc
$ 1.98
(102.35%)
33.18M
TNONTenon Medical Inc
$ 5.326
(74.05%)
33.2M
OBLGOblong Inc
$ 5.41
(59.59%)
22.51M
MNTXManitex International Inc
$ 5.6189
(47.48%)
4.5M
FULCFulcrum Therapeutics Inc
$ 3.495
(-60.51%)
26.64M
ONCTOncternal Therapeutics Inc
$ 1.726
(-58.46%)
432.64k
MODVModivCare Inc
$ 14.50
(-53.51%)
1.49M
STRMStreamline Health Solutions Inc
$ 0.2304
(-52.19%)
782.18k
SYRASyra Health Corporation
$ 0.3856
(-51.81%)
3.18M
NVDANVIDIA Corporation
$ 118.9493
(1.74%)
213.97M
SQQQProShares UltraPro Short QQQ
$ 8.455
(-0.88%)
105.01M
PEGYPineapple Energy Inc
$ 0.1821
(4.54%)
99.49M
SMFLSmart for Life Inc
$ 1.11
(30.59%)
84.17M
MULNMullen Automotive Inc
$ 0.1744
(-0.34%)
56.15M

CDIO Discussion

View Posts
Awl416 Awl416 4 months ago
Cardio Diagnostics Holdings, Inc. Announces the Availability of Its Clinical Tests at Family Medicine Specialists’ Retail Healthcare Clinic at Walmart Supercenter in Round Lake Beach, Illinois, That Offers Walk-In Appointments Seven Days a Week
👍️0
tw0122 tw0122 4 months ago
Unfortunately dilution so catch it now .54- .58 nice short play
👍️0
rosemountbomber rosemountbomber 4 months ago
I think I am joining your logic. Only a small position here, but think I will unload on any uptick.
👍️0
Whalatane Whalatane 4 months ago
RMB. I think I posted previously that most won't pay for their tests so I was not investing in it.
Advances in AI are making their tech redundant
JMO
Kiwi
👍️0
Whalatane Whalatane 4 months ago
RMB. I don't have a position in CDIO but will chk the news
Kiwi
👍️0
rosemountbomber rosemountbomber 4 months ago
North, Kiwi, as we all have interest here in CDIO and have also experienced Amarin here is another example of how insurance companies only think of today and saving money. Today CDIO released a study showing their technology identifying CVD could save the insurers 113 million. Yeah I guess some would say it is small potatoes. But the stock not going up on the news, because everyone knows insurers don't give a hoot.
👍️0
luckydude777 luckydude777 5 months ago
Below $.80 excellant value price.
👍️0
YankeMike YankeMike 5 months ago
Looks like it was because of this:

Benchmark Maintains Speculative Buy on Cardio Diagnostics Hldgs, Lowers Price Target to $1.35
7:47 am ET April 19, 2024 (Benzinga) Print
Benchmark analyst Bruce Jackson maintains Cardio Diagnostics Hldgs (NASDAQ:CDIO) with a Speculative Buy and lowers the price target from $4 to $1.35.
👍️0
rosemountbomber rosemountbomber 5 months ago
North this along with HSCS has taken a beating. Are they going kaput?
👍️0
Triple nickle Triple nickle 5 months ago
Ok bounce time 1.03
👍️0
tw0122 tw0122 6 months ago
Let’s go nice flipper
👍️0
Monksdream Monksdream 6 months ago
CDIO under $2
👍️0
north40000 north40000 6 months ago
A new notice of allowance for a patent application, titled:

Compositions And Methods For Detecting Predisposition To Cardiovascular Disease.
👍️0
rosemountbomber rosemountbomber 6 months ago
There has to be some news that we are not privy to. Huge beat down
👍️0
Monksdream Monksdream 7 months ago
CDIO under $2
👍️0
luckydude777 luckydude777 7 months ago
As expected, Market Makers are loading up on cheap shares before the next run starts. Get 'em while they're cheap, laddies.
👍️0
luckydude777 luckydude777 7 months ago
This could be a HUGE positive marketing move with this morning's news. EASY ACCESS to the test may make all the difference in the world to CDIO. Stay tuned folks ...!!!
👍️0
saigai saigai 7 months ago
there is no other way to interpret the recent ..last 6 weeks of in play.....this is gonna be huge... its coming
👍️0
luckydude777 luckydude777 7 months ago
If their brain/s are working right, they release a good PR, and as the whole world scrambles to pick up shares, they'll start selling their shares at much higher prices.

Appears she is heading higher though, as you say.
👍️0
saigai saigai 7 months ago
todays filing is good news.. they are getting ready to sell some shares but they could have done that at higher prices a bunch of weeks back.. we gonna pop and then monster
👍️0
luckydude777 luckydude777 8 months ago
The dip of the dip of the DIP! Gollllyyyyyyyyyyyyyyyyyyyy ... they sure are trying to shake out the weak, feeble and creating frightattacks.

This could be grounds for a CLASS-ACTION LAWSUIT on behalf of insiders having coronaries.
👍️0
Runners123 Runners123 8 months ago
Buy the dip
👍️0
luckydude777 luckydude777 8 months ago
VERY GOOD news! Company is NOT cash strapped!

"The First Convertible Debenture has been fully repaid, and as of January 4, 2024, the Company’s obligation to issue and sell, and Yorkville’s obligation to purchase, the Second Convertible Debenture has been terminated. At the time of termination, there were no outstanding borrowings, advance notices or shares of Common Stock to be issued under the Securities Purchase Agreement. In addition, there were no fees due by the Company or Yorkville in connection with the termination of the Securities Purchase Agreement.
👍️0
luckydude777 luckydude777 8 months ago
Yep - predictable as the ocean will be wet come sundown.
👍️0
luckydude777 luckydude777 8 months ago
More like I wonder how LOW they'll puke it just to show us that they CAN?
👍️0
luckydude777 luckydude777 8 months ago
Will be interesting to see what kind of upside we get today from the news a bit earlier.
👍️0
saigai saigai 8 months ago
sorry about the post wrong board for sure
👍️0
saigai saigai 8 months ago
building a small position in intc...good value a few bucks i wont have to baby sit
👍️0
luckydude777 luckydude777 8 months ago
I'm in agreement.
👍️0
saigai saigai 8 months ago
it was a great trade on news day for many.. i can only hold.. the real buyers of this news added value will join us before weeks end ..
👍️0
saigai saigai 8 months ago
still moves on a whisper. no dillution yet.. they have had a 100 different opps to sell into strength and they have not..they will offering in double digits or if they are really lucky get some big boy debt financing based on orders. revenue monster..imo
👍️0
Whalatane Whalatane 8 months ago
This is just my opinion as a secondary prevention coronary heart disease patient with a family history of early heart attacks.
Their test is a risk calculator ...not IMHO a diagnostic test.
Diagnostic tests are done if you are in the ER with chest pains and they are doing Tropin tests , EKG readings etc and deciding weither or not to send you to the Cath lab for an angiogram.
CDIO's test is a combination of a DNA test and a lipid panel ....if I have that wrong , please correct.

Have you checked how much cash on hand they have ...chk the latest 10Q...because if they are low on COH ( which they probably are ) they are likely to use this news event to raise cash
Last 10Q they had $4.5m in cash , prepaid expenses etc and were running close to $2m in loss's each Qt
They may have had a cash infusion since that report

Kiwi
👍️0
luckydude777 luckydude777 8 months ago
They can always drop the $350 price of the test. And/or ... insurance companies may come to believe that $350 for the test is MUCH CHEAPER than all the extensive/EXPENSIVE testing for heart conditions the way it is currently being done.
👍️0
Whalatane Whalatane 8 months ago
CHICAGO, January 02, 2024--(BUSINESS WIRE)--Cardio Diagnostics Holdings, Inc. (Nasdaq: CDIO), an AI-driven precision cardiovascular medicine company, today announced that the American Medical Association (AMA) has assigned a dedicated Current Procedural Terminology (CPT®) Proprietary Laboratory Analysis (PLA), 0440U, for the company’s AI-driven coronary heart disease (CHD) detection test, PrecisionCHD. Receipt of this new CPT PLA code, which will be effective on April 1, 2024, is a significant step toward payer billing and payment, facilitating broader adoption of the first and only integrated genetic-epigenetic diagnostic blood test for CHD.


Congrats on the move.
Doubt if payers or patients will pay the $350 ? the Co wants for this test ...but so far the mkt's buying the hype
No position
Good luck
Kiwi
👍️0
Whalatane Whalatane 8 months ago
North. Happy New Year . Are U still in CDIO and do you have any explanation on current stock movements ...short covering or an actual fundamental story playing out ?
Congrats if you are still in this .
No position
Kiwi
👍️0
Bud-Wiser Bud-Wiser 8 months ago
Sold half of mine @2.65 weeks ago .. she did go all the way back down to like 1.25 and I felt good about it then …but now I’m not feeling so great
👍️0
luckydude777 luckydude777 8 months ago
Now that coding will be set in place (April), the company can NOW release news about OTHER medical facilities who plan to use the test ... or are already administering it.
👍️0
1hot toddy 1hot toddy 9 months ago
too bad u didnt buy when it was 32 cents $$$$$$$$$$
👍️0
UNDAUNTED UNDAUNTED 9 months ago
Sold my stake at 2.36 (at 32 cent loss) but buying back as it drops to lower my avg
👍️0
luckydude777 luckydude777 9 months ago
So it could get shorted back to near $2.00 per A/H.
👍️0
UNDAUNTED UNDAUNTED 9 months ago
So anyone know why this shot up 40% in the last 5 min of trading Friday?
👍️0
S3lfMade S3lfMade 9 months ago
R/S vote today!?
👍️0
luckydude777 luckydude777 9 months ago
Back into CDIO at $2.17. This is where I STICKING for the next several weeks.
👍️0
conix conix 9 months ago
CDIO will be fine come January. Biotech investors are looking forward to more biotech conferences in the new year.
👍️0
UNDAUNTED UNDAUNTED 9 months ago
I'm still holding but you're in a better position than me. I won't even break even until it hits 2.65.
👍️0
Acehole Acehole 9 months ago
Same here. I made a very nice chunk of money selling at 1.83 but damn did I feel stupid when it rocketed up to 2.30 shortly after. Always happens that way.
👍️0
UNDAUNTED UNDAUNTED 9 months ago
So no one knows why this shot up 5 minutes before closing bell?
👍️0
luckydude777 luckydude777 9 months ago
With HUBC ... I feel that is a pretty MEATY PR they released this morning. Of the same caliber of news when CDIO got FDA approval of their testing.

I know this may be stretching things a bit, but my gut feeling is that the government may get behind HUBC behind closed doors. Should that happen down the road, I see HUBC becoming a big-boy stock much more than CDIO, but what the hey do I know???

I DON'T think a person can go wrong holding CDIO shares, that's for SURE. I just don't have enough available cash at the present to hold shares in both companies to make it worth my while sitting in BOTH companies -- at the present anyway.
👍️0
saigai saigai 9 months ago
hubc ill give a look.. i have some powder for monday thanks
👍️0
luckydude777 luckydude777 9 months ago
Noooooooooooooooo ... it went up because I dumped all my CDIO shares earlier before the liftoff and put the proceeds into HUBC. ALWAYS happens that way when I sell a good stock more than not.

I think CDIO has so much potential, but I also think HUBC can have MORE ... depending how things play out. We'll see ...
👍️0

Your Recent History

NASDAQ
CDIO
Cardio Diagnostics
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved